Kathleen Kalaher

Statistics

Publications

Citations

432

H-Index

Active since

1976

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Kathleen Kalaher is an author at Memorial Sloan Kettering Cancer Center specializing in chemotherapy resistance, platinum-based agents, and chemotherapy.

Publications per year

1976–1980

Publications

Studies of cross-resistance, synergistic combinations and blocking of activity of platinum derivatives

Joseph H. Burchenal, Kathleen Kalaher, Kimberly Dew et al. · Biochimie · 1978 · 157 citations

Pharmacy, Chemistry, Medicinal Chemistry +11

Lack of cross-resistance between certain platinum coordination compounds in mouse leukemia.

Joseph H. Burchenal, Kathleen Kalaher, Tara O’Toole et al. · PubMed · 1977 · 105 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Rationale for development of platinum analogs.

Burchenal Jh, Kathleen Kalaher, Kevin Dew et al. · PubMed · 1980 · 82 citations

Medicine, Oncology, Pharmacology +16

Antileukemic effects of pseudoisocytidine, a new synthetic pyrimidine C-nucleoside.

Joseph H. Burchenal, K. Ciovacco, Kathleen Kalaher et al. · PubMed · 1976 · 70 citations

Medicine, Oncology, Pharmacology +14

Synergistic effects of the combination of cis-platinum diamminodichloride and 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in transplanted mouse leukemias.

Joseph H. Burchenal, Tara O’Toole, Kathleen Kalaher et al. · PubMed · 1977 · 18 citations

Medicine, Oncology, Pharmacology +15

1–5 of 5